Said company can no longer make certain claims about the better
digestibility of its product. They also had a tad bit of trouble about a particular
researcher's credibility and quality of research that claims were based upon.
It was in the popular press a while back. I happened by said company's
booth at a conference this spring. Asked the rep about it. Without skipping a
beat she told me the two bigger US formula companies did similar things.
These days I make more effort to find out the funding of a speaker or
researcher and take that into consideration when listening to a talk or reading a
paper. It isn't enough to read the disclaimer in the beginning of a peer
reviewed journal article or look at the financial connection to a speaker in the
conference syllabus.
What is really spooky is that many of the "health segments" in TV news and
public interest programs are directly taken from public relations departments
of large pharmaceutical companies. No disclaimers put into the broadcast.
I have learned one has to be particularly careful reading stuff on
Medscape/WebMD as there is a lot of stuff inserted between legitimate articles that
are really product placement and advertisement masquerading as new information.
Way slicker than having a drug or formula rep detail you in the office.
Glad I learned very early to check sources and "read between the lines."
Daughter of a journalist and librarian,
Pierrette Mimi Poinsett MD
Petaluma CA
***********************************************
To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html